![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Formento Jean-Louis Etienne-Grimaldi Marie-Christine Francoual Mireille Pagèès Gilles Onesto Cercina Formento Patricia Chamorey Emmanuel Dassonville Olivier Poissonnet Gilles Milano Géérard
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.10, Iss.8, 2009-08, pp. : 1277-1283
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 4, 2012-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
VEGF Inhibitors in Cancer Therapy
Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
VEGF Signaling in Cancer Treatment
Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. :